InspireMD, Inc. - SIC # 3850 -

Ticker Exchange SIC # Website Latest Ticker
NSPR Nasdaq 3850 www.inspiremd.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for InspireMD, Inc.

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Apr 8th, 2025 1:00 pm
InspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare Conference - Mar 26th, 2025 1:00 pm
InspireMD Full Year 2024 Earnings: US$0.76 loss per share (vs US$0.82 loss in FY 2023) - Mar 13th, 2025 10:18 am
InspireMD Inc (NSPR) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Rising Expenses and ... - Mar 13th, 2025 7:04 am
InspireMD Reports Fourth Quarter and Full Year 2024 Financial Results - Mar 12th, 2025 11:00 am
InspireMD to Announce Fourth Quarter and Full Year 2024 Financial Results - Feb 26th, 2025 1:00 pm
Investors in InspireMD (NASDAQ:NSPR) have unfortunately lost 78% over the last five years - Feb 24th, 2025 10:04 am
InspireMD and NAMSA to Partner on CGUARDIANS II Pivotal Clinical Trial of the CGuard Prime™ 80 cm Carotid Stent System for Use in TCAR procedures - Feb 13th, 2025 12:00 pm
Here's Why We're Watching InspireMD's (NASDAQ:NSPR) Cash Burn Situation - Jan 14th, 2025 10:47 am
InspireMD Announces Expected Retirement of its CFO Craig Shore and CFO Transition in 2025 - Dec 12th, 2024 12:00 pm
InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures (TCAR) - Dec 9th, 2024 12:00 pm
InspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to its Board of Directors - Nov 25th, 2024 9:05 pm
InspireMD Third Quarter 2024 Earnings: US$0.16 loss per share (vs US$0.15 loss in 3Q 2023) - Nov 14th, 2024 10:17 am
InspireMD Inc (NSPR) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Rising Costs and ... - Nov 13th, 2024 7:09 am
InspireMD Reports Third Quarter 2024 Financial Results and Provides Business Update - Nov 12th, 2024 12:00 pm
InspireMD to Report Third Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, November 12th - Nov 4th, 2024 1:00 pm
One InspireMD Insider Raised Stake By 13% In Previous Year - Oct 21st, 2024 1:34 pm
InspireMD Announces Establishment of Global Headquarters in Miami, Florida to Support Anticipated U.S. Launch and Commercialization of the CGuard Prime Carotid Stent System - Oct 15th, 2024 11:00 am
InspireMD Advances with FDA Study Approval and Global Goals - Oct 8th, 2024 11:28 am
InspireMD Announces Approval of Investigational Device Exemption (IDE) Application for CGUARDIANS II Pivotal Study of the CGuard Prime 80cm Carotid Stent System - Oct 7th, 2024 11:00 am